[{"Assets_0_Q3_USD":1533431000.0,"CommonStockSharesOutstanding_0_Q3_shares":37333015.0,"EarningsPerShareBasic_1_Q3_USD":0.57,"EarningsPerShareBasic_3_Q3_USD":1.18,"EarningsPerShareDiluted_1_Q3_USD":0.57,"EarningsPerShareDiluted_3_Q3_USD":1.17,"NetIncomeLoss_1_Q3_USD":21389000.0,"NetIncomeLoss_3_Q3_USD":43984000.0,"StockholdersEquity_0_Q3_USD":907925000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":37494000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":37486000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":37320000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":37303000.0,"Ticker":"TECH","CIK":"842023","name":"BIO-TECHNE CORP","OfficialName":"Bio-Techne Corp Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16235870966.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"SP500","filed":"20170510"}]